ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,745
-1,06%
Bitcoin
63 047,73
6,63%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) Actualités

WGS GeneDx Holdings Corporation

19,66
0,16 (0,82%)
Après les heures de négociation
Dernière mise à jour : 22:33:21
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
GeneDx Holdings Corporation WGS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,16 0,82% 19,66 22:33:21
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,47 19,09 21,71 19,66 19,50
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202422:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/4/202414:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04/4/202422:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/3/202413:30GLOBEGeneDx to Present Data at the 2024 American College of..
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
23/2/202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202422:28EDGAR2Form 8-K - Current report
20/2/202422:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01/2/202422:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24/1/202422:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
23/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:58EDGAR2Form 8-K - Current report
08/1/202414:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
04/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
28/11/202322:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
20/11/202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
17/11/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202321:33EDGAR2Form 8-K - Current report
30/10/202321:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
23/10/202323:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202322:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
03/10/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
20/9/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202314:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
06/9/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/8/202313:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
09/8/202302:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08/8/202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:13EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/8/202314:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
27/7/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202323:04EDGAR2Form 8-K - Current report
22/7/202303:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202313:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

Dernières Valeurs Consultées

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés